港股異動丨世紀睿科(1450.HK)復牌暴漲23% 公司控制權或出現變動
格隆匯7月22日丨世紀睿科(1450.HK)復牌暴漲23%,報0.48港元創近三年半新高,成交額放大至673萬港元。

董事會獲吿知公司主席、執行董事兼控股股東盧志森先生及執行董事梁榮輝先生計劃可能出售Cerulean Coast Limited及Future Miracle Limited持有的全部或部分股份予若干名獨立第三方。
此外,若干獨立認購人擬認購公司將發行的可換股債券。擬進行的交易一旦落實,可能會導致公司的控制權出現變動以及就所有已發行股份提出收購守則項下的強制性全面要約。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.